Fatigue in Healthy Individuals
NCT00888563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114
Last updated 2019-12-09
Summary
Background:
* People with many different diseases have symptoms of fatigue, which is a general sense of tiredness; however, the causes are not fully understood. Fatigue symptoms may be related to a person s level of fitness, health, and blood chemistries.
* Researchers are studying the potential role of plasma cytokines (signaling molecules) and hypothalamic-pituitary-adrenal (HPA) axis (part of the neuroendocrine system that controls stress) functioning in symptoms of fatigue.
Objectives:
* To characterize the symptoms of fatigue in healthy individuals.
* To collect information on fatigue, pain, depression, stress, sleepiness, and quality of life from healthy adults of all ages.
* To compare results obtained from people with various illnesses to better understand possible causes of fatigue that are associated with those diseases.
Eligibility:
* Physically and mentally healthy volunteers18 years of age or older who can speak and read the English language.
* Exclusion criteria include individuals with a disease or condition causing significant fatigue (congestive heart failure, cancer, or sleep disorders), individuals taking medicines that cause fatigue (beta blockers, diuretics, or narcotics), and individuals who have a major psychiatric condition (major depression, anxiety disorder, or schizophrenia).
* The following individuals may not participate: those who have two more alcoholic drinks per day, who use illicit drugs, or who drink more than 4 cups of coffee, 8 cups of soda or tea, or similar amounts of other caffeine-containing beverages a day, or eat more than 1 pound of chocolate per day; and individuals who worked evenings or night shifts in the past month.
* Women who are pregnant or breastfeeding are not eligible.
Design:
* Participants must make two outpatient visits to the Clinical Center. Each visit will last 5 hours and participants must refrain from smoking and consuming alcohol and caffeine for at least 24 hours.
* During the first study visit, researchers will conduct the following tests:
* Psychiatric interview, medical history, pregnancy test, and drug test.
* Urine test to measure the levels of stress hormones.
* Questionnaires that measure fatigue, pain, depression, stress, daytime sleepiness, and activity.
* Physical fitness test, including strength tests, walking tests, and physical activity monitoring.
* Before the second study visit, patients must refrain from smoking and consuming caffeine and alcohol for at least 24 hours and have nothing, even water, by mouth after midnight. During the second study visit, the following tests will be conducted:
* Stress hormone test (participant will receive a cortisol-releasing hormone).
* Four intravenous blood draws to determine cytokine profiles, gene expression, and levels of stress hormones (immune and gentic analysis).
* Participants will receive a small financial compensation for participation in the study.
Conditions
- Healthy Volunteer
- Fatigue
- Depression
Sponsors & Collaborators
-
National Institute of Nursing Research (NINR)
lead NIH
Principal Investigators
-
Leorey N Saligan, C.R.N.P. · National Institute of Nursing Research (NINR)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-23
- Completion
- 2017-11-16
Countries
- United States
Study Locations
More Related Trials
-
Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862
NCT04682769 ·Status: COMPLETED
-
Disentangling the Role of Depression in Hypersomnia
NCT05850676 ·Status: RECRUITING
-
FaReWell Depression - Facial Exercise Program to Treat Depression
NCT03983291 ·Status: RECRUITING ·Phase: NA
-
Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression
NCT07082998 ·Status: RECRUITING ·Phase: NA
-
Cognitive, Psychological, and Physical Functioning in Long-COVID Patients With Different Levels of Fatigue.
NCT05758558 ·Status: COMPLETED
-
The Association Between Physical Symptoms and Depression Among Medical Students in Egypt
NCT06820814 ·Status: COMPLETED
-
Body Awareness in People With Depressive Disorder
NCT06879977 ·Status: RECRUITING
-
Depression and Increased Health Services Utilization Among Elderly Primary Care Patients
NCT00279526 ·Status: COMPLETED
-
Genetic and Biochemical Markers of Interferon-Induced Depression.
NCT00252538 ·Status: COMPLETED
-
Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression
NCT03756246 ·Status: UNKNOWN ·Phase: PHASE4
-
Neurocardiac Control in Major Depression
NCT00084162 ·Status: COMPLETED
-
Assesment of Vitamin B6 Level in Patients With Major Depressive Disorder
NCT05649293 ·Status: NOT_YET_RECRUITING
-
DOC Utility: Screening of Depression, Obstructive Sleep Apnea and Cognitive Impairment
NCT02363114 ·Status: UNKNOWN
-
The Pathogenesis of Depression - Possible Autoimmune Mechanisms
NCT05293899 ·Status: RECRUITING
-
Depression Prevention in Older Spousally-bereaved Adults
NCT04016896 ·Status: COMPLETED ·Phase: NA
-
Leucine in Midlife Depression
NCT06580145 ·Status: RECRUITING ·Phase: PHASE2
-
RESISTance Exercise for Depression Trial
NCT06110897 ·Status: RECRUITING ·Phase: NA
-
Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression
NCT03690856 ·Status: UNKNOWN ·Phase: NA
-
Stress and Inflammation in Late-Life Depression
NCT02389465 ·Status: COMPLETED ·Phase: PHASE4
-
Stress and the Sympathetic Nervous System in Adults With Depression
NCT04838262 ·Status: COMPLETED ·Phase: NA
-
Predictors of Depression Treatment Response to Exercise
NCT02583867 ·Status: COMPLETED ·Phase: PHASE3
-
Exercise and Severe Depression: Clinical and Biological Analysis
NCT01899716 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion
NCT02026622 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Physiologic Sensors to Assess Depression
NCT02568865 ·Status: COMPLETED
-
MIND Diet in Relation to Malnutrition and Depression in AD
NCT07163923 ·Status: COMPLETED